LANK-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LANK-2, covering 2016-12-20 to 2016-12-20. Get the full timeline:
Most recent: Clinical Trial Update: "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia [Phase 2]